Treg Functional Stability and Its Responsiveness to the Microenvironment

Overview

Journal Immunol Rev

Specialties Allergy & Immunology
General Surgery

Date 2014 Apr 10

PMID 24712463

Citations 146

Authors

Joseph Barbi

Drew Pardoll

Fan Pan

Affiliations

Soon will be listed here.

Abstract

Regulatory T cells (Tregs) prevent autoimmunity and tissue damage resulting from excessive or unnecessary immune activation through their suppressive function. While their importance for proper immune control is undeniable, the stability of the Treg lineage has recently become a controversial topic. Many reports have shown dramatic loss of the signature Treg transcription factor Forkhead box protein 3 (Foxp3) and Treg function under various inflammatory conditions. Other recent studies demonstrate that most Tregs are extremely resilient in their expression of Foxp3 and the retention of suppressive function. While this debate is unlikely to be settled in the immediate future, improved understanding of the considerable heterogeneity within the Foxp3(+) Treg population and how Treg subsets respond to ranging environmental cues may be keys to reconciliation. In this review, we discuss the diverse mechanisms responsible for the observed stability or instability of Foxp3(+) Treg identity and function. These include transcriptional and epigenetic programs, transcript targeting, and posttranslational modifications that appear responsive to numerous elements of the microenvironment. These mechanisms for Treg functional modulation add to the discussion of Treg stability.

Citing Articles

Regenerative Functions of Regulatory T Cells and Current Strategies Utilizing Mesenchymal Stem Cells in Immunomodulatory Tissue Regeneration.

Ahn J, Kim B, Bello A, Moon J, Arai Y, Lee S Tissue Eng Regen Med. 2025; 22(2):167-180.

PMID: 39804546 PMC: 11794763. DOI: 10.1007/s13770-024-00690-w.

Combinatorial genetic engineering strategy for immune protection of stem cell-derived beta cells by chimeric antigen receptor regulatory T cells.

Barra J, Robino R, Castro-Gutierrez R, Proia J, Russ H, Ferreira L Cell Rep. 2024; 43(11):114994.

PMID: 39561045 PMC: 11659569. DOI: 10.1016/j.celrep.2024.114994.

Th17/Treg cell balance in patients with papillary thyroid carcinoma: a new potential biomarker and therapeutic target.

Huo M, Adeerjiang Y, Abulitipu A, Khan U, Li X, Zhang L Front Oncol. 2024; 14:1325575.

PMID: 39534095 PMC: 11554530. DOI: 10.3389/fonc.2024.1325575.

Integrative biomarker discovery and immune profiling for ulcerative colitis: a multi-methodological approach.

Jiang L, Zhang S, Jiang C, Chen H, Huang J, Yang J Sci Rep. 2024; 14(1):24290.

PMID: 39414957 PMC: 11484944. DOI: 10.1038/s41598-024-75797-0.

Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.

Hu T, Liu C, Lei M, Zeng Q, Li L, Tang H Signal Transduct Target Ther. 2024; 9(1):268.

PMID: 39379377 PMC: 11461632. DOI: 10.1038/s41392-024-01954-6.

References

Zanin-Zhorov A, Cohen I . Signaling via TLR2 and TLR4 Directly Down-Regulates T Cell Effector Functions: The Regulatory Face of Danger Signals. Front Immunol. 2013; 4:211. PMC: 3722573. DOI: 10.3389/fimmu.2013.00211. View

Takahashi R, Nishimoto S, Muto G, Sekiya T, Tamiya T, Kimura A . SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production. J Exp Med. 2011; 208(10):2055-67. PMC: 3182063. DOI: 10.1084/jem.20110428. View

Kwan W, van der Touw W, Paz-Artal E, Li M, Heeger P . Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med. 2013; 210(2):257-68. PMC: 3570105. DOI: 10.1084/jem.20121525. View

Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan A, Stroud J . FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 2006; 126(2):375-87. DOI: 10.1016/j.cell.2006.05.042. View

Xiao S, Jin H, Korn T, Liu S, Oukka M, Lim B . Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol. 2008; 181(4):2277-84. PMC: 2722959. DOI: 10.4049/jimmunol.181.4.2277. View

Sugamura K, Ishii N, Weinberg A . Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol. 2004; 4(6):420-31. DOI: 10.1038/nri1371. View

Boone D, Turer E, Lee E, Ahmad R, Wheeler M, Tsui C . The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004; 5(10):1052-60. DOI: 10.1038/ni1110. View

Josefowicz S, Lu L, Rudensky A . Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012; 30:531-64. PMC: 6066374. DOI: 10.1146/annurev.immunol.25.022106.141623. View

Dang E, Barbi J, Yang H, Jinasena D, Yu H, Zheng Y . Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011; 146(5):772-84. PMC: 3387678. DOI: 10.1016/j.cell.2011.07.033. View

10.

Li C, Ebert P, Li Q . T cell receptor (TCR) and transforming growth factor β (TGF-β) signaling converge on DNA (cytosine-5)-methyltransferase to control forkhead box protein 3 (foxp3) locus methylation and inducible regulatory T cell differentiation. J Biol Chem. 2013; 288(26):19127-39. PMC: 3696685. DOI: 10.1074/jbc.M113.453357. View

11.

Raffin C, Pignon P, Celse C, Debien E, Valmori D, Ayyoub M . Human memory Helios- FOXP3+ regulatory T cells (Tregs) encompass induced Tregs that express Aiolos and respond to IL-1β by downregulating their suppressor functions. J Immunol. 2013; 191(9):4619-27. DOI: 10.4049/jimmunol.1301378. View

12.

Blatner N, Mulcahy M, Dennis K, Scholtens D, Bentrem D, Phillips J . Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med. 2012; 4(164):164ra159. PMC: 3762575. DOI: 10.1126/scitranslmed.3004566. View

13.

Yamazaki S, Okada K, Maruyama A, Matsumoto M, Yagita H, Seya T . TLR2-dependent induction of IL-10 and Foxp3+ CD25+ CD4+ regulatory T cells prevents effective anti-tumor immunity induced by Pam2 lipopeptides in vivo. PLoS One. 2011; 6(4):e18833. PMC: 3080372. DOI: 10.1371/journal.pone.0018833. View

14.

Pellet-Many C, Frankel P, Jia H, Zachary I . Neuropilins: structure, function and role in disease. Biochem J. 2008; 411(2):211-26. DOI: 10.1042/BJ20071639. View

15.

Solomon B, Mueller C, Chae W, Alabanza L, Bynoe M . Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2011; 108(5):2040-5. PMC: 3033275. DOI: 10.1073/pnas.1008721108. View

16.

Rudra D, Egawa T, Chong M, Treuting P, Littman D, Rudensky A . Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat Immunol. 2009; 10(11):1170-7. PMC: 2764816. DOI: 10.1038/ni.1795. View

17.

Zhan Y, Davey G, Graham K, Kiu H, Dudek N, Kay T . SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus. Immunol Cell Biol. 2009; 87(6):473-80. DOI: 10.1038/icb.2009.23. View

18.

Isomura I, Palmer S, Grumont R, Bunting K, Hoyne G, Wilkinson N . c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J Exp Med. 2009; 206(13):3001-14. PMC: 2806473. DOI: 10.1084/jem.20091411. View

19.

Chong M, Rasmussen J, Rudensky A, Rundensky A, Littman D . The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med. 2008; 205(9):2005-17. PMC: 2526196. DOI: 10.1084/jem.20081219. View

20.

Zhou X, Bailey-Bucktrout S, Jeker L, Penaranda C, Martinez-Llordella M, Ashby M . Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol. 2009; 10(9):1000-7. PMC: 2729804. DOI: 10.1038/ni.1774. View